Energenesis Biomedical Co (TPE:6657) Beneish M-Score: -3.05 (As of Jun. 27, 2026)


TPE:6657 Energenesis Biomedical Co Ltd TPE:6657
64 GF Score
Price NT$34.90
GF Value NT$51.28
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Energenesis Biomedical Co Beneish M-Score?

Energenesis Biomedical Co TPE:6657 -2.92% 64 Beneish M-Score is -3.05 as of Jun. 27, 2026. GuruFocus rates TPE:6657 with a GF Score™ of 64/100 and a GF Value™ of NT$51.28 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 831 Biotechnology companies, Energenesis Biomedical Co ranks better than 75.93% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.05 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Energenesis Biomedical Co's Beneish M-Score or its related term are showing as below:

TPE:6657' s Beneish M-Score Range Over the Past 10 Years
Min: -3.05   Med: -2.93   Max: -2.27
Current: -3.05

During the past 11 years, the highest Beneish M-Score of Energenesis Biomedical Co was -2.27. The lowest was -3.05. And the median was -2.93.


Energenesis Biomedical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Energenesis Biomedical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Energenesis Biomedical Co Beneish M-Score Chart

Energenesis Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -2.27 -2.90 -2.96 -3.05

Energenesis Biomedical Co Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.96 -3.23 -2.62 -2.95 -3.05

TPE:6657 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Energenesis Biomedical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Energenesis Biomedical Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Energenesis Biomedical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Energenesis Biomedical Co's Beneish M-Score falls into.


TPE:6657
64GF Score
Energenesis Biomedical Co Ltd TPE:6657
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Energenesis Biomedical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Energenesis Biomedical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9496+0.528 * 0.9662+0.404 * 0.2808+0.892 * 0.9903+0.115 * 1.0379
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0804+4.679 * -0.037927-0.327 * 1.0497
=-3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$1.88 Mil.
Revenue was 2.815 + 1.582 + 2.064 + 1.213 = NT$7.67 Mil.
Gross Profit was 2.018 + 1.238 + 1.596 + 0.98 = NT$5.83 Mil.
Total Current Assets was NT$864.43 Mil.
Total Assets was NT$948.98 Mil.
Property, Plant and Equipment(Net PPE) was NT$78.72 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$22.57 Mil.
Selling, General, & Admin. Expense(SGA) was NT$86.68 Mil.
Total Current Liabilities was NT$43.42 Mil.
Long-Term Debt & Capital Lease Obligation was NT$9.29 Mil.
Net Income was -64.792 + -49.008 + -47.629 + -96.973 = NT$-258.40 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0.00 Mil.
Cash Flow from Operations was -19.054 + -35.383 + -52.086 + -115.887 = NT$-222.41 Mil.
Total Receivables was NT$2.00 Mil.
Revenue was 2.596 + 2.115 + 1.63 + 1.408 = NT$7.75 Mil.
Gross Profit was 1.949 + 1.407 + 1.229 + 1.105 = NT$5.69 Mil.
Total Current Assets was NT$687.75 Mil.
Total Assets was NT$780.64 Mil.
Property, Plant and Equipment(Net PPE) was NT$75.79 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$22.81 Mil.
Selling, General, & Admin. Expense(SGA) was NT$81.01 Mil.
Total Current Liabilities was NT$35.83 Mil.
Long-Term Debt & Capital Lease Obligation was NT$5.47 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.878 / 7.674) / (1.997 / 7.749)
=0.244722 / 0.257711
=0.9496

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5.69 / 7.749) / (5.832 / 7.674)
=0.734288 / 0.759969
=0.9662

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (864.431 + 78.715) / 948.982) / (1 - (687.746 + 75.792) / 780.638)
=0.00615 / 0.021905
=0.2808

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7.674 / 7.749
=0.9903

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(22.805 / (22.805 + 75.792)) / (22.571 / (22.571 + 78.715))
=0.231295 / 0.222844
=1.0379

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(86.677 / 7.674) / (81.012 / 7.749)
=11.294892 / 10.45451
=1.0804

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.287 + 43.422) / 948.982) / ((5.473 + 35.832) / 780.638)
=0.055543 / 0.052912
=1.0497

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-258.402 - 0 - -222.41) / 948.982
=-0.037927

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Energenesis Biomedical Co has a M-score of -3.05 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.05 mean?
Energenesis Biomedical Co (TPE:6657) has a Beneish M-Score of -3.05 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Energenesis Biomedical Co and its competitors. According to the industry distribution chart, Energenesis Biomedical Co ranks #200 out of 831 companies in the Biotechnology industry, placing it in the top 24.1%.
Is Energenesis Biomedical Co's Beneish M-Score too high?
Energenesis Biomedical Co's current Beneish M-Score is -3.05. Based on the distribution chart, Energenesis Biomedical Co ranks #200 out of 831 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Energenesis Biomedical Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Energenesis Biomedical Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Energenesis Biomedical Co ranks #200 out of 831 companies for Beneish M-Score. This places Energenesis Biomedical Co in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Energenesis Biomedical Co and its competitors. Energenesis Biomedical Co's current Beneish M-Score is -3.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Energenesis Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Energenesis Biomedical Co (TPE:6657) is currently considered Possible Value Trap. The stock's GF Value™ is NT$51.28, compared to a current price of NT$34.90 — trading 31.9% below its estimated fair value. The current Beneish M-Score is -3.05. Energenesis Biomedical Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Energenesis Biomedical Co (TPE:6657), the current Beneish M-Score is -3.05 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Energenesis Biomedical Co (TPE:6657) Overvalued in 2026?

Based on GuruFocus' analysis, Energenesis Biomedical Co stock appears to be undervalued. The current stock price of NT$34.90 is trading 31.9% below its estimated GF Value™ of NT$51.28. GuruFocus considers Energenesis Biomedical Co to be Possible Value Trap.

Key valuation signals for TPE:6657:

  • Beneish M-Score: -3.05
  • GF Value™: NT$51.28 vs. price of NT$34.90 (31.9% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the TPE:6657 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Energenesis Biomedical Co Business Description

Address No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492
Energenesis Biomedical Co Ltd is a biomedicine company. The company is engaged in businesses related to biological experimentation and analysis, as well as new drugs development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. The product pipeline of the company consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream,F708, Asthama treatment, and others.
64GF Score

Get the complete analysis for TPE:6657

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.90
Price
NT$51.28
GF Value